Creative Medical Technology Holdings

A clinical-stage biotechnology company.

Creative Medical Technology Holdings, Inc. (CMTH) is a clinical-stage biotechnology company focused on treating erectile dysfunction and stroke using stem cell treatments. Since 2011 Creative Medical Technology Holdings, Inc. (CMTH) and their affiliate company Creative Medical Health, Inc. have focused on regenerative medical solutions for unmet Urological and Neurological needs. Through their own research and collaborations with leading academic institutions, CMT has acquired a groundbreaking stem cell (Amniostem), developed proprietary protocols, built an extensive intellectual property portfolio, developed complete treatment offerings for erectile dysfunction, launched a 40-patient trial for ED at UCLA and are breaking new ground for treating stroke using their newly acquired amniotic fluid-based stem cell.Their team consists of leading international researchers in regenerative medicine.Their “science-first” approach to treatments ensures that all of their treatments are proven to be both safe and effective.